Newsletter | April 30, 2024

Best of April: Top 5 Insights In Clinical Supply Chain & Logistics

Clinical Supply Leader

TOP 5 INSIGHTS IN CLINICAL SUPPLY CHAIN & LOGISTICS  

APRIL EDITION

#1 - How To Prevent And Manage Temperature Excursions In Clinical Trials

Temperature excursions can have devastating effects on drug product for clinical trials. Here are some ways to avoid them and protect the cold chain.

#2 - Build For The Future: Optimizing Autologous Cell Therapy Clinical Trials

Review current requirements as outlined by the EU Clinical Trial Regulation, supporting guidance, and three key considerations when planning IMP labeling activities for ongoing studies.

#3 - When Does GMP Matter In Non-GMP Settings?

Would you ever need to follow GMP standards in workspaces where GMP is not required or possible? This article digs into why, when, and how to follow the principles of GMP.

#4 - Outsourcing Your Highly Potent Oncology Drug Product

Precision oncology treatments require specialized manufacturing and packaging, leading companies to outsource production. Assessing a CDMO’s highly potent processing capabilities is critical.

#5 - Best Practices For Clinical Supply Chain Management In Rare Disease Trials

A supply chain pro discusses three of the greatest challenges in clinical trial supply management for rare diseases and strategies to overcome them.